Minimal interference of concizumab with standard clinical coagulation laboratory assays - An in vitro study.

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2024)

The presence of concizumab did not, or only slightly, influence the outcome of standard clinical coagulation assays relevant for HA and HB.

Keyphrases